O'Shaughnessy Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.9M | Sell |
120,764
-49,887
| -29% | -$9.38M | 0.11% | 202 |
|
|
2026
Q1 | $33.7M | Buy |
170,651
+4,959
| +3% | +$956K | 0.17% | 126 |
|
|
2025
Q4 | $30.5M | Buy |
165,692
+21,541
| +15% | +$3.78M | 0.17% | 130 |
|
|
2025
Q3 | $22.1M | Buy |
144,151
+23,579
| +20% | +$3.57M | 0.13% | 167 |
|
|
2025
Q2 | $16.9M | Sell |
120,572
-7,531
| -6% | -$1.06M | 0.11% | 204 |
|
|
2025
Q1 | $18.8M | Buy |
128,103
+38,576
| +43% | +$5.58M | 0.15% | 155 |
|
|
2024
Q4 | $11.7M | Sell |
89,527
-13,715
| -13% | -$1.92M | 0.1% | 212 |
|
|
2024
Q3 | $16.1M | Buy |
103,242
+29,734
| +40% | +$4.8M | 0.14% | 160 |
|
|
2024
Q2 | $11.5M | Buy |
73,508
+17,678
| +32% | +$2.66M | 0.12% | 189 |
|
|
2024
Q1 | $7.56M | Buy |
55,830
+8,483
| +18% | +$1.12M | 0.08% | 267 |
|
|
2023
Q4 | $6.38M | Buy |
47,347
+3,642
| +8% | +$473K | 0.08% | 268 |
|
|
2023
Q3 | $5.92M | Buy |
43,705
+2,397
| +6% | +$327K | 0.09% | 252 |
|
|
2023
Q2 | $5.91M | Buy |
41,308
+4,294
| +12% | +$632K | 0.09% | 245 |
|
|
2023
Q1 | $5.14M | Sell |
37,014
-195
| -0.5% | -$26.2K | 0.08% | 270 |
|
|
2022
Q4 | $5.05M | Buy |
37,209
+6,583
| +21% | +$826K | 0.08% | 260 |
|
|
2022
Q3 | $3.36M | Sell |
30,626
-3,612
| -11% | -$458K | 0.06% | 292 |
|
|
2022
Q2 | $4.52M | Buy |
34,238
+3,058
| +10% | +$401K | 0.08% | 243 |
|
|
2022
Q1 | $4.14M | Buy |
31,180
+9,740
| +45% | +$1.17M | 0.07% | 280 |
|
|
2021
Q4 | $2.5M | Buy |
21,440
+551
| +3% | +$64.8K | 0.04% | 333 |
|
|
2021
Q3 | $2.51M | Buy |
20,889
+5,053
| +32% | +$588K | 0.05% | 281 |
|
|
2021
Q2 | $1.9M | Sell |
15,836
-1,833
| -10% | -$201K | 0.04% | 331 |
|
|
2021
Q1 | $1.76M | Buy |
17,669
+5,682
| +47% | +$571K | 0.04% | 282 |
|
|
2020
Q4 | $1.2M | Sell |
11,987
-4,376
| -27% | -$464K | 0.03% | 305 |
|
|
2020
Q3 | $1.79M | Buy |
16,363
+995
| +6% | +$111K | 0.05% | 197 |
|
|
2020
Q2 | $1.63M | Buy |
15,368
+9,170
| +148% | +$947K | 0.05% | 196 |
|
|
2020
Q1 | $554K | Sell |
6,198
-969
| -14% | -$91.2K | 0.02% | 282 |
|
|
2019
Q4 | $715K | Buy |
7,167
+5,390
| +303% | +$507K | 0.02% | 338 |
|
|
2019
Q3 | $158K | Buy |
1,777
+1,250
| +237% | +$108K | ﹤0.01% | 568 |
|
|
2019
Q2 | $44K | Buy |
527
+397
| +305% | +$31.1K | ﹤0.01% | 738 |
|
|
2019
Q1 | $11K | Buy |
+130
| New | +$10.2K | ﹤0.01% | 776 |
|
|
2018
Q1 | – | Sell |
-24,373
| Closed | -$1.69M | – | 911 |
|
|
2017
Q4 | $1.69M | Sell |
24,373
-4,929
| -17% | -$332K | 0.04% | 212 |
|
|
2017
Q3 | $1.99M | Sell |
29,302
-51,091
| -64% | -$3.23M | 0.05% | 201 |
|
|
2017
Q2 | $5.48M | Sell |
80,393
-45,559
| -36% | -$2.98M | 0.13% | 118 |
|
|
2017
Q1 | $7.84M | Buy |
125,952
+80,111
| +175% | +$4.66M | 0.18% | 86 |
|
|
2016
Q4 | $4.75M | Sell |
45,841
-58,675
| -56% | -$3.33M | 0.11% | 126 |
|
|
2016
Q3 | $6.87M | Buy |
104,516
+29,412
| +39% | +$1.92M | 0.16% | 107 |
|
|
2016
Q2 | $4.54M | Buy |
+75,104
| New | +$4.36M | 0.12% | 135 |
|
|
2015
Q3 | – | Sell |
-70
| Closed | -$4K | – | 897 |
|
|
2015
Q2 | $4K | Buy |
+70
| New | +$4.79K | ﹤0.01% | 848 |
|
|
2014
Q2 | – | Sell |
-942,484
| Closed | -$61.1M | – | 972 |
|
|
2014
Q1 | $61.1M | Sell |
942,484
-278,788
| -23% | -$18M | 1.21% | 25 |
|
|
2013
Q4 | $72.5M | Sell |
1,221,272
-281,025
| -19% | -$15.3M | 1.52% | 19 |
|
|
2013
Q3 | $77.9M | Sell |
1,502,297
-117,164
| -7% | -$5.88M | 1.87% | 9 |
|
|
2013
Q2 | $76.7M | Buy |
+1,619,461
| New | +$82.5M | 2.05% | 6 |
|
Other funds holding AZN
EP
IA
O'Shaughnessy Asset Management's AZN Position: Q2 2026 in Review
O'Shaughnessy Asset Management reduced its AstraZeneca (AZN) stake by 29% in Q2 2026, selling an estimated $9.38M and leaving 120,764 shares worth $22.9M. The position accounts for 0.11% of the portfolio, ranked #202.
O'Shaughnessy Asset Management first reported a position in AZN in Q2 2013 and has held it in 42 quarters since. The position peaked at $77.9M in Q3 2013. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- O'Shaughnessy Asset Management held 120,764 shares of AstraZeneca worth $22.9M as of Q2 2026.
- O'Shaughnessy Asset Management sold 49,887 AstraZeneca shares in Q2 2026, an estimated $9.38M.
- AstraZeneca made up 0.11% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #202 holding.
- O'Shaughnessy Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 42 quarters since.
- O'Shaughnessy Asset Management's AstraZeneca position peaked at $77.9M in Q3 2013.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.